KINETIQ THERAPEUTICS LLC
Biotech · Private
Enzyme replacement therapy (ERT) for Fabry disease, likely an improved formulation or delivery method to reduce infusion burden
- Grants
- $603K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 1 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Preclinical Efficacy of Subcutaneous Enzyme Therapy for Lysosomal Fabry Disease | $295,923 | |
| Federal grant | Department of Health and Human Services · Phase I · Evaluating a Novel Enzymatic Modality for the Treatment of Fanconi Anemia | $306,870 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2216 | Avenzo Therapeutics | — | $79M |
| 2217 | Oragenics, Inc. | — | $67M |
| 2218 | Discidium Biosciences, LLC | — | — |
| 2219 | KINETIQ THERAPEUTICS LLC | — | — |
| 2220 | Immuneering Corp | — | $77M |
| 2221 | Pheast Therapeutics | — | $50M |
| 2222 | Tmunity Therapeutics | — | $140M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Subcutaneous Therapeutic Enzyme Formulations, Uses, And Methods For Generating Thereofapplication
- Subcutaneous Therapeutic Enzyme Formulations, Uses, And Methods For Generating Thereofgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.